Copyright
©The Author(s) 2016.
World J Gastroenterol. Jun 21, 2016; 22(23): 5400-5405
Published online Jun 21, 2016. doi: 10.3748/wjg.v22.i23.5400
Published online Jun 21, 2016. doi: 10.3748/wjg.v22.i23.5400
Table 1 Patient characteristics
| Patient characteristics | n (%) |
| Total number | 10.0 |
| Average age (yr) | 65.4 |
| Gender | |
| Female | 2 (20) |
| Male | 8 (80) |
| Location | |
| Colon | 8 (80) |
| Rectum | 2 (20) |
| UICC | |
| 1 + 2 + 3 | 0 (0) |
| 4 | 10 (100) |
| Metastases | |
| Liver | 6 (60) |
| Lung | 8 (80) |
| Lymph nodes | 5 (50) |
| Prior ctx regimen | |
| 3 | 7 (70) |
| 4 | 2 (20) |
| 5 | 0 (0) |
| 6 | 1 (10) |
- Citation: Martchenko K, Schmidtmann I, Thomaidis T, Thole V, Galle PR, Becker M, Möhler M, Wehler TC, Schimanski CC. Last line therapy with sorafenib in colorectal cancer: A retrospective analysis. World J Gastroenterol 2016; 22(23): 5400-5405
- URL: https://www.wjgnet.com/1007-9327/full/v22/i23/5400.htm
- DOI: https://dx.doi.org/10.3748/wjg.v22.i23.5400